Just - Evotec Biologics Introduces J.TRAIN for Efficient Continuous Manufacturing of Biologics
Just - Evotec Biologics Launches J.TRAIN
Overview
On June 30, 2026, Evotec SE unveiled an innovative solution in biopharmaceutical manufacturing with the launch of J.TRAIN. This initiative represents a significant upgrade in the company’s Just – Evotec Biologics services, particularly in the realm of continuous manufacturing technology. J.TRAIN allows biopharmaceutical companies to integrate Evotec's cutting-edge technology directly into their existing facilities, creating a more flexible and productive operation.
Key Features
J.TRAIN combines prefabricated modular cleanroom designs with industry-standard manufacturing equipment, augmented by automation processes that comply with current good manufacturing practices (cGMP). This advanced setup is developed to expedite installation timelines and enhance cost efficiency when compared to traditional manufacturing methods.
Fast and Flexible Deployment
The standout feature of J.TRAIN is its speed of deployment, which can take as little as 18 months to fully operationalize. This is a stark contrast to outdated methods that require significantly longer periods for facility setup. Biopharmaceutical companies can achieve high-performance capacity for biologics manufacturing right on their premises, thereby embedding sophisticated production capabilities into their workflow.
Statement from Leadership
Dr. Linda Zuckerman, Executive Vice President and Global Head of Just – Evotec Biologics, emphasizes that J.TRAIN is a
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.